Effect of intragastric administration on the morphology of laboratory rats’ gastrointestinal tract

Abstract

BACKGROUND: In preclinical studies on laboratory animals, oral administration with special probe for test substances is very in demand. Most studies are devoted to the psychophysiological and clinical-biochemical reaction of the animal’s body to this effect, but extremely few studies consider the effect of the manipulation itself on the development of pathology in the tissues of the gastrointestinal tract associated with the inevitable mechanical impact of the probe on the mucous membranes.

AIM: To identify pathological changes in the organs of the gastrointestinal tract of laboratory rats that are associated with the effects of intragastric administration of the tested substances, and compare the data obtained with the frequency of spontaneous diseases.

MATERIALS AND METHODS: The data of pathomorphological observations obtained from Wistar rats involved in the course of scientific work carried out at NPO Dom Pharmacy in the period from 2018 to 2021 were used. 1400 sentinel animals were analyzed, and the same number of intact rats. Intact animals were gavaged with a control substance (distilled water) for 14 days.

RESULTS: In less than 5% of clinically healthy animals, inflammatory diseases of insignificant intensity and prevalence in all parts of the intestine can be detected. As a result of the anipulation of intragastric administration, an almost twofold increase in the number of cases of catarrhal esophagitis and gastritis, erosive and ulcerative lesions of the mucous membrane of the esophagus and stomach in its glandular part and hyperkeratosis in its non-glandular part was noted.

CONCLUSIONS: The type and frequency of occurrence of the background pathology of the gastrointestinal tract of laboratory rats were determined. It has been proven that repeated traumatization of the mucous membrane associated with mechanical contact of a solid metal probe with the epithelium provokes the development of inflammatory diseases of the esophagus and stomach, without affecting the underlying parts of the intestine.

Keywords

biomedical research / rats / drug administration routes / pharmaceutical vehicles / digestive system / historical control data

References

[1] Germann PG, Ockert D. Granulomatous inflammation of the oropharyngeal cavity as a possible cause for unexpected high mortality in a Fischer 344 rat carcinogenicity study. Lab Anim Sci. 1994;44:338–343.

[2] Germann P.G., Ockert D. Granulomatous inflammation of the oropharyngeal cavity as a possible cause for unexpected high mortality in a Fischer 344 rat carcinogenicity study // Lab Anim Sci. 1994. Vol. 44. P. 338–343.

[3] Hoggatt AF, Hoggatt J, Honerlaw M, Pelus LM. A spoonful of sugar helps the medicine go down: a novel technique to improve oral gavage in mice. J Am Assoc Lab Anim Sci. 2010;49(3):329–334.

[4] Hoggatt A.F., Hoggatt J., Honerlaw M., Pelus L.M. A spoonful of sugar helps the medicine go down: a novel technique to improve oral gavage in mice // J Am Assoc Lab Anim Sci. 2010. Vol. 49, No. 3. P. 329–334.

[5] Turner PV, Vaughn E, Sunohara-Neilson J, et al. Oral gavage in rats: animal welfare evaluation. J Am Assoc Lab Anim Sci. 2012;51(1):25–30.

[6] Turner P.V., Vaughn E., Sunohara-Neilson J., et al. Oral gavage in rats: animal welfare evaluation // J Am Assoc Lab Anim Sci. 2012. Vol. 51, No. 1. P. 25–30.

[7] Nebendhal C. Routes of administration. In: The laboratory rat. Ed. by G.J. Krinke. London: Academic Press; 2000. P. 463–483. DOI: 10.1016/B978–012426400–7.50063–7

[8] Nebendhal C. Routes of administration. In: The laboratory rat. Ed. by G.J. Krinke. London: Academic Press, 2000. P. 463–483. DOI: 10.1016/B978-012426400-7.50063-7

[9] Murphy SJ, Smith P, Shaivitz AB, et al. The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats. Contemp Top Lab Anim Sci. 2001;40(2):9–12.

[10] Murphy S.J., Smith P., Shaivitz A.B., et al. The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats // Contemp Top Lab Anim Sci. 2001. Vol. 40. No 2. P. 9–12.

[11] Larcombe AN, Wang KCW, Phan JA, et al. Confounding Effects of Gavage in Mice: Impaired Respiratory Structure and Function. Am J Respir Cell Mol Biol. 2019;61(6):791–794. DOI: 10.1165/rcmb.2019-0242LE

[12] Larcombe A.N., Wang K.C.W., Phan J.A., et al. Confounding Effects of Gavage in Mice: Impaired Respiratory Structure and Function // Am J Respir Cell Mol Biol. 2019. Vol. 61, No. 6. P. 791–794. DOI: 10.1165/rcmb.2019-0242LE

[13] Arantes-Rodrigues R, Henriques A, Pinto-Leite R, et al. The effects of repeated oral gavage on the health of male CD-1 mice. Lab Anim. 2012;41(5):129–134. DOI: 10.1038/laban0512-129

[14] Arantes-Rodrigues R., Henriques A., Pinto-Leite R., et al. The effects of repeated oral gavage on the health of male CD-1 mice // Lab Anim. 2012. Vol. 41, No. 5. P. 129–134. DOI: 10.1038/laban0512-129

[15] Turner PV, Pekow C, Vasbinder MA, Brabb T. Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation. J Am Assoc Lab Anim Sci. 2011;50(5):614–627.

[16] Turner P.V., Pekow C., Vasbinder M.A., Brabb T. Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation // J Am Assoc Lab Anim Sci. 2011. Vol. 50, No. 5. P. 614–627.

[17] Long GG, Hardisty JF. Regulatory forum opinion piece: thresholds in toxicologic pathology. Toxicol Pathol. 2012;40(7):1079–1081. DOI: 10.1177/0192623312443322

[18] Long G.G., Hardisty J.F. Regulatory forum opinion piece: thresholds in toxicologic pathology // Toxicol Pathol. 2012. Vol. 40, No. 7. P. 1079–1081. DOI: 10.1177/0192623312443322

[19] McInnes EF. Background Lesions in Laboratory Animals. A Color Atlas. Elsevier Health Sciences, 2011. 256 p.

[20] Sahota PS, Popp JA, Hardisty JF, et al., editors. Toxicologic Pathology: Nonclinical Safety Assessment. 2nd ed. CRC Press; 2018. 1224 p. DOI: 10.1201/9780429504624

[21] Sahota P.S., Popp J.A., Hardisty J.F., et al., editors. Toxicologic Pathology: Nonclinical Safety Assessment. 2nd ed. CRC Press, 2018. 1224 p. DOI: 10.1201/9780429504624

[22] Blankenship B, Skaggs H. Findings in Historical Control Harlan RCCHanTM: WIST Rats from 4-, 13-, 26-Week Studies. Toxicol Pathol. 2013;41(3):537–547. DOI: 10.1177/0192623312460925

[23] Blankenship B., Skaggs H. Findings in Historical Control Harlan RCCHanTM: WIST Rats from 4-, 13-, 26-Week Studies // Toxicol Pathol. 2013. Vol. 41, No 3. P. 537–547. DOI: 10.1177/0192623312460925

[24] Tucker MJ. Diseases of the wistar rat. London: Taylor & Francis, 1997. 254 p.

[25] Tucker M.J. Diseases of the wistar rat. London: Taylor & Francis, 1997. 254 p.

[26] Damsch S, Eichenbaum G, Looszova A, et al. Unexpected Nasal Changes in Rats Related to Reflux after Gavage Dosing. Toxicologic Pathology. 2011;39(2):337–347. DOI: 10.1177/0192623310388430

[27] Damsch S., Eichenbaum G., Looszova A., et al. Unexpected Nasal Changes in Rats Related to Reflux after Gavage Dosing // Toxicologic Pathology. 2011. Vol. 39, No. 2. P. 337–347. DOI: 10.1177/0192623310388430

[28] Damsch S, Eichenbaum G, Tonelli A, et al. Gavage-Related Reflux in Rats: Identification, Pathogenesis, and Toxicological Implications (Review). Toxicologic Pathology. 2011;39(2):348–360. DOI: 10.1177/0192623310388431

[29] Damsch S., Eichenbaum G., Tonelli A., et al. Gavage-Related Reflux in Rats: Identification, Pathogenesis, and Toxicological Implications (Review) // Toxicologic Pathology. 2011. Vol. 39, No. 2. P. 348–360. DOI: 10.1177/0192623310388431

[30] Makarenko IE, Avdeeva OI, Vanati GV, et al. Possible ways of administration and standard drugs in laboratory animals. International Bulletin of Veterinary Medicine. 2013;(3):78–84. (In Russ.)

[31] Макаренко И.Е., Авдеева О.И., Ванатиев Г.В. и др. Возможные пути и объемы введения лекарственных средств лабораторным животным // Международный вестник ветеринарии. 2013. № 3. С. 78–84.

[32] Rybakova AV, Makarova MN, Kukharenko AE, et al. Current requirements for and approaches to dosing in animal studies. Тhе Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2018;8(4):207–217. (In Russ.) DOI: 10.30895/1991-2919-2018-8-4-207-217

[33] Рыбакова А.В., Макарова М.Н., Кухаренко А.Е., и др. Существующие требования и подходы к дозированию лекарственных средств лабораторным животным // Ведомости Научного центра экспертизы средств медицинского применения. 2018. Т. 8, № 4. С. 207–217. DOI: 10.30895/1991-2919-2018-8-4-207-217

[34] McInnes EF, Scudamore CL. Review of approaches to the recording of background lesions in toxicologic pathology studies in rats. Toxicol Lett. 2014;229(1):134–143. DOI: 10.1016/j.toxlet.2014.06.005

[35] McInnes E.F., Scudamore C.L. Review of approaches to the recording of background lesions in toxicologic pathology studies in rats // Toxicol Lett. 2014. Vol. 229, No. 1. P. 134–143. DOI: 10.1016/j.toxlet.2014.06.005

[36] Nolte T, Brander-Weber P, Dangler C, et al. Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse. J Toxicol Pathol. 2016;29(1S):1S-125S. DOI: 10.1293/tox.29.1S

[37] Nolte T., Brander-Weber P., Dangler C., et al. Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse // J Toxicol Pathol. 2016. Vol. 29, No. 1S. P. 1S-125S. DOI: 10.1293/tox.29.1S

[38] Walker MK, Boberg JR, Walsh MT, et al. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice. Toxicol Appl Pharmacol. 2012;260(1):65–69. DOI: 10.1016/j.taap.2012.01.025

[39] Walker M.K., Boberg J.R., Walsh M.T., et al. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice // Toxicol Appl Pharmacol. 2012. Vol. 260, No. 1. P. 65–69. DOI: 10.1016/j.taap.2012.01.025

RIGHTS & PERMISSIONS

ECO-vector LLC